Patricia Judson, M.D., F.A.C.O.G., F.A.C.S.

judso003@umn.edu
612-626-3111, office
Preferred method of contact:  e-mail

Dr. Judson's Clinical Profile
(University of Minnesota Physicians Web site)

Dr. Judson is Associate Professor in the Department of Obstetrics, Gynecology and Women’s Health, Division of Gynecologic Oncology.  Dr. Judson is board certified in obstetrics and gynecology and has a subspecialty board certification in gynecologic oncology.  Dr. Judson is the Medical Director of Gynecologic Oncology at North Memorial Medical Center and the Director of the Gynecologic Oncology Fellowship Program at the University of Minnesota.

Dr. Judson received her medical degree in 1992 from the University of Minnesota School of Medicine.  She completed her Obstetrics and Gynecology residency at the University of California, San Francisco and completed a Gynecologic Oncology Fellowship from the University of North Carolina, Chapel Hill.

Research Interests

• Gynecologic Oncology Group Study #210, A Molecular Staging Study of Endometrial Carcinoma, Clinical Study Co-Chair

• The Incidence and Treatment of Gynecologic Malignancies in Organ Transplant Recipients, Principal Investigator

• Vulvar Cancer in Young Women, Principal Investigator

• Outcomes in Ovarian Cancer Patients using Complementary Alternative Modalities: A Prospective, Randomized Trial, Principal Investigator

• Hereditary Aspects of Cervical Cancer, Washington University, Co-Investigator

• Role of HER2 and EGFR in Endometrial Cancer, Co-Investigator
     

Selected Publications

Downs LS Jr, Judson PL, Argenta PA, Carson LF, Boente MP.  A Phase I study of ifosfamide, paclitaxel, and carboplatin in advanced and recurrent cervical cancer.  Gynecol Oncol.  2004;95(2):347-51.

Geller MA, Argenta P, Bradley W, Dusenbery KE, Brooker D, Downs LS Jr, Judson PL, Carson LF, Boente MP.  Treatment and recurrence patterns in endometrial stromal sarcomas and the relationship to c-kit expression.  Gynecol Oncol.  2004;95:632-6.

Argenta PA, Kubicek GJ, Dusenbery KE, Judson PL, Downs LS, Carson LF, Boente MP.  Widespread lymph node metastases in a young woman with FIGO stage IA1 squamous cervical cancer.  Gynecol Oncol.  2005;97(2):659-61.

Mitchell SK, Carson LF, Judson P, Downs LS Jr.  Efficacy and tolerability of lower dose topotecan in recurrent ovarian cancer:  A retrospective case review.  Int J Gynecol Cancer.  2005;15(5):793-8.

Dusenbery KE, Potish RA, Argenta PA, Judson PL.  On the apparent failure of adjuvant pelvic radiotherapy to improve survival for women with uterine sarcomas confined to the uterus.  Am J Clin Oncol.  2005;28(3):295-300.

Jonson AL, Bliss RL, Truskinovsky A, Judson P, Argenta P, Carson L, Dusenbery K, Downs LS Jr.  Clinical features and outcomes of uterine and ovarian carcinosarcoma.  Gynecol Oncol.  2006;100(3):561-4.

Judson PL, Habermann EB, Baxter NN, Durham SB, Virnig BA.  Trends in the incidence of invasive and in situ vulvar carcinoma.  Obset Gynecol.  2006;107(5):1018-22.

Argenta PA, Ghebre R, Dusenbery KE, Chen MD, Judson PL, Downs LS Jr, Carson LF.  Radiation therapy with concomitant and adjuvant cisplatin and paclitaxel in high-risk cervical cancer:  Long-term follow-up.  Eur J Gynaecol Oncol.  2006;27(3):231-5.

Chura JC, Truskinovsky AM, Judson PL, Johnson L, Geller MA, Downs LS Jr.  Positron emission tomography and leiomyomas:  Clinicopathologic analysis of 3 cases of PET scan-positive leiomyomas and literature review.  Gynecol Oncol. 2007;104(1):247-52.

Goudge CS, Downs LS, Judson PL, Argenta PA.  Stage II squamous cell carcinoma of the vagina in a patient with Bloom syndrome:  A case report.  J Reprod Med. 2007;52(6):557-9.

Chura JC, Van Iseghem K, Downs LS Jr, Carson LF, Judson PL.  Bevacizumab plus cyclophosphamide in heavily pretreated patients with recurrent ovarian cancer.  Gynecol Oncol. 2007;107(2):326-30.

Downs LS Jr, Judson PL, Argenta PA, Ghebre R, Geller MA, Bliss RL, Boente MP, Nahhas WA, Abu-Ghazaleh SZ, Chen MD, Carson LF.  A prospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma.  Cancer 2008;112(2):331-9.

Clinics:

• Women's Health Center
  612-626-3444

• Hubert H. Humphrey Cancer Center
  763-520-7887